NEW YORK (GenomeWeb News) – Germany's Indivumed said today that it will conduct clinical research on personalized medicines for cancer in partnership with Georgetown University.

The trials will be conducted at the recently founded Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown.

Since 2007, Hamburg-based Indivumed and Georgetown have collaborated to establish a biobank and clinical database for analyzing tumor specimens to improve cancer diagnostics and to better understand the complex interaction of the cells within a tumor, Indivumed said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Sponsored by

This webinar will address a range of methods for optimizing small RNA library preparation.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.